PRAヘルスサイエンス、FDAシニアオフィサーを分散型臨床試験戦略のグローバル･センター･オブ･エクセレンス統括者に任命

    NEXT STORY
    Olema Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    PREV STORY
    Saniona Reports Positive Topline Results from Tesomet Phase 2 Open-Label Extension Study in Hypothalamic Obesity
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Dermira Presents New Data from its Phase 3 Clinical Program Evaluating Glycopyrronium Tosylate (QBREXZA™ (glycopyrronium) cloth) in Patients with Primary Axillary Hyperhidrosis

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Announces Participation at the Evercore ISI 3rd Annual HealthCONx Virtual Conference

    author_avatar
    NASDAQ Market News

    Biocartis Group NV: Results of the extraordinary shareholders’ meeting held on 11 September 2017

    PRESS RELEASE: REGULATED INFORMATION11 September 2017, 17:40 CEST                                                            Results of the extraordinary shareholders' meeting ...

    author_avatar
    NASDAQ Market News